Pelliciari, D. H. S., C. R. A. Reis, and C. A. Bordini. “Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? – a Pharmacoeconomic Study”. Headache Medicine, vol. 15, no. Supplement, Aug. 2024, p. 98, https://headachemedicine.com.br/index.php/hm/article/view/1230.